Scherbaum, Norbert

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 2,498

Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders

23andMe Research Team, Walters, R. K., Polimanti, R., Johnson, E. C., McClintick, J. N., Adams, M. J., Adkins, A. E., Aliev, F., Bacanu, S.-A., Batzler, A., et al. (2018) · Nature Neuroscience

Genetic Associations and EpidemiologySubstance Abuse Treatment and Outcomes

Cited by 632

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I. E., Pedersen, N. L., Stringa, N., Zettergren, A., Hernández, I., et al. (2021) · Nature Communications

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 324

Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders

Hatoum, A. S., Colbert, S. M. C., Johnson, E. C., Huggett, S. B., Deak, J. D., Pathak, G. A., Jennings, M. V., Paul, S. E., Karcher, N. R., Hansen, I., et al. (2023) · Nature Mental Health

Genetic Associations and EpidemiologySubstance Abuse Treatment and Outcomes

Cited by 241

Genome‐wide significant association between alcohol dependence and a variant in the ADH gene cluster

Frank, J., Cichon, S., Treutlein, J., Ridinger, M., Mattheisen, M., Hoffmann, P., Herms, S., Wodarz, N., Soyka, M., Zill, P., et al. (2012) · Addiction Biology

Genetic Associations and EpidemiologyAlcohol Consumption and Health Effects

Cited by 176

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Jansen, I. E., van der Lee, S. J., Gomez-Fonseca, D., de Rojas, I., Dalmasso, M. C., Grenier-Boley, B., Zettergren, A., Mishra, A., Ali, M., Andrade, V., et al. (2022) · Acta Neuropathologica

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 132

New/emerging psychoactive substances and associated psychopathological consequences

Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021) · Psychological Medicine

Forensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

Cited by 119

Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease

Le Guen, Y., Belloy, M. E., Grenier-Boley, B., de Rojas, I., Castillo-Morales, A., Jansen, I., Nicolas, A., Bellenguez, C., Dalmasso, C., Küçükali, F., et al. (2022) · JAMA Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 93

Opiate Treatment in Depression Refractory to Antidepressants and Electroconvulsive Therapy

Nyhuis, P. W., Gastpar, M., & Scherbaum, N. (2008) · Journal of Clinical Psychopharmacology

Treatment of Major DepressionOpioid Use Disorder Treatment

Cited by 90

Group psychotherapy for opiate addicts in methadone maintenance treatment - a controlled trial

Scherbaum, N., Kluwig, J., Specka, M., Krause, D., Merget, B., Finkbeiner, T., & Gastpar, M. (2005) · European Addiction Research

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 89

The impact of alcohol dependence on social brain function

Gizewski, E. R., Müller, B. W., Scherbaum, N., Lieb, B., Forsting, M., Wiltfang, J., Leygraf, N., & Schiffer, B. (2013) · Addiction Biology

Schizophrenia research and treatmentSubstance Abuse Treatment and Outcomes

Cited by 56

Evidence-Based Guidelines for the Pharmacologic Management of Methamphetamine Dependence, Relapse Prevention, Chronic Methamphetamine-Related, and Comorbid Psychiatric Disorders in Post-Acute Settings

Härtel-Petri, R., Krampe-Scheidler, A., Braunwarth, W.-D., Havemann-Reinecke, U., Jeschke, P., Looser, W., Mühlig, S., Schäfer, I., Scherbaum, N., Bothe, L., et al. (2017) · Pharmacopsychiatry

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 39

Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts

Bonnet, U., Specka, M., Soyka, M., Alberti, T., Bender, S., Grigoleit, T., Hermle, L., Hilger, J., Hillemacher, T., Kuhlmann, T., et al. (2020) · Frontiers in Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 29

Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy

Schlaak, J. F., Trippler, M., Hoyo-Becerra, C., Erim, Y., Kis, B., Wang, B., Scherbaum, N., & Gerken, G. (2012) · PLoS ONE

Tryptophan and brain disordersinterferon and immune responses

Cited by 25

The effect of deviance predictability on mismatch negativity in schizophrenia patients

Horacek, M., Kärgel, C., Scherbaum, N., & Müller, B. W. (2016) · Neuroscience Letters

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 9

Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias

EADB, Bellenguez, C., Castillo Morales, A., Amin, N., van der Lee, S. J., Muntaner, M., Parveen, K., Küçükali, F., Grenier-Boley, B., Heikkinen, S., et al. (2026) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 7